SuperworthBoston Scientific market cap BSX
Share price times shares outstanding: what the whole company sells for, since 2009.
- Today, Oct 23, 2026
- $66.2B
- Highest close in our data
- $158.9B
- Sep 2025
Boston Scientific is worth $66.2B at the close on Oct 23, 2026, at $45.69 a share.
That is down 56% over the last year and up 8% over five years.
Its highest close in our data was $158.9B in Sep 2025.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $66.2B | $61.7B | $144.7B | −54% |
| 2025 | $142.4B | $132.4B | $158.9B | +7% |
| 2024 | $133.6B | $85.2B | $133.6B | +58% |
| 2023 | $84.7B | $65.3B | $84.7B | +28% |
| 2022 | $66.3B | $51.5B | $66.7B | +9% |
| 2021 | $60.5B | $50.7B | $64.8B | +18% |
| 2020 | $51.5B | $38B | $63.7B | −18% |
| 2019 | $63B | $47.3B | $63.2B | +31% |
| 2018 | $48B | $35.6B | $53.4B | +41% |
| 2017 | $34B | $30.2B | $40.7B | +16% |
| 2016 | $29.5B | $22.4B | $33B | +19% |
| 2015 | $24.8B | $17.5B | $25.3B | +42% |
| 2014 | $17.5B | $15.1B | $18.1B | +8% |
| 2013 | $16.1B | $8.1B | $16.5B | +110% |
| 2012 | $7.7B | $7.1B | $9.1B | −3% |
| 2011 | $7.9B | $7.6B | $11.8B | −31% |
| 2010 | $11.5B | $8.1B | $14.2B | −15% |
| 2009 | $13.6B | $12.2B | $17.2B | n/a |
Against its peers
Companies in Medical - Devices nearest Boston Scientific's size, closest first, today.
| Company | Market cap |
|---|---|
| BSXBoston Scientific | $66.2B |
| EWEdwards Lifesciences | $51.3B |
| SYKStryker | $117.8B |
| MDTMedtronic | $122B |
| GEHCGE HealthCare Technologies | $32.3B |
| DXCMDexCom | $29.4B |
| ABTAbbott Laboratories | $179.4B |
| ZBHZimmer Biomet | $18.8B |
| Peer median | $51.3B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Boston Scientific
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.